Physician profile
Damian E Grovas Abad
NPI 1992900849
$497,961.52
in general payments reported to CMS, 2019-2025
18 companies · $162K in 2025
The $162K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $42K · 2021: $12K · 2022: $13K · 2023: $42K · 2024: $170K · 2025: $162K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $196K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $159K · Food and Beverage: $11K · Travel and Lodging: $7,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $195,839.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $158,750.00 |
| Food and Beverage | $11,334.16 |
| Travel and Lodging | $7,404.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $322,776.16 | 2019-2025 | Absolute Pro, Supera, Optis |
| Boston Scientific Corporation | $98,110.00 | 2019-2025 | Avvigo Guidance System, Synergy, Opticross |
| Medtronic, INC. | $37,447.48 | 2020-2025 | Hawkone, Corevalve Evolut R, Cardiosight Reader |
| Medtronic Vascular, INC. | $22,732.47 | 2019-2020 | |
| Terumo Medical Corporation | $15,095.52 | 2019-2025 | Glidesheath Slender, R2p Misago, Access |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $498.88 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $313.82 | 2019-2022 | |
| Asahi Intecc USA, INC. | $301.77 | 2022-2025 | Peripheral Vascular, Asahi Peripheral Vascular Wires, Asahi Ptca Guide Wire |
| Janssen Pharmaceuticals, INC | $176.67 | 2019-2022 | |
| Edwards Lifesciences Corporation | $120.26 | 2019-2023 | |
| Amgen INC. | $119.03 | 2022 | |
| W. L. Gore & Associates, INC. | $84.60 | 2023 | Gore Cardioform Septal Occluder |
| E.R. Squibb & Sons, L.L.C. | $45.00 | 2019-2022 | |
| Teleflex LLC | $43.01 | 2019 | |
| Dexcom, INC. | $27.59 | 2025 | Dexcom G6 Transmitter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.77 | 2019 | |
| Biotronik INC. | $24.49 | 2019 | |
| Pfizer Pharmaceuticals LLC | $20.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damian Grovas Abad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.